Stocktoria
Protara Therapeutics, Inc. TARA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-10-22
Protara Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2,831,208 | $14.8M |
| CITADEL ADVISORS LLC | 1,232,458 | $6.4M |
| Point72 Asset Management, L.P. | 1,152,714 | $6.0M |
| RENAISSANCE TECHNOLOGIES LLC | 125,700 | $654,897 |
| AQR CAPITAL MANAGEMENT LLC | 66,805 | $348,053 |
| BlackRock Finance, Inc. | 115,273 | $239,767 |
| TWO SIGMA INVESTMENTS, LP | 37,838 | $197,136 |
Source: SEC EDGAR filings · CIK 0001359931 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.